NIH Guide: Weekly Index for January 17, 2020

Funding Opportunities

• NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed)
  (PAR-20-080)
  National Institute of Mental Health
  Application Receipt Date(s): May 26, 2020; May 25, 2021; May 25, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed)
  (PAR-20-081)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  Application Receipt Date(s): April 1, 2020, April 1, 2021, and April 1, 2022
• Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
  (PAR-20-086)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): June 17, 2020
• Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed)
  (PAR-20-088)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  Application Receipt Date(s): April 1, 2020, April 1, 2021, and April 1, 2022 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Biomedical Data Repository (U24 - Clinical Trials Not Allowed)
  (PAR-20-089)
  National Institute of General Medical Sciences
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023
• NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed
  (PAR-20-090)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): March 2, 2020; July 1, 2020; November 2, 2020; March 1, 2021; July 1, 2021;November 1, 2021; March 1, 2022; July 1, 2022; November 1, 2022;
• Revision Applications - FSMA Human Foods Preventive Controls Implementation Expansion Supplement to RFA-FD-18-001 (U18 Clinical Trials Not Allowed)
  (PAR-20-091)
  Food and Drug Administration
  Application Receipt Date(s): March 25, 2020, by 11:59 PM Eastern Time. March 25, 2021, by 11:59 PM Eastern Time. March 25, 2022, by 11;59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)
  (PAR-20-093)
  National Institute of Mental Health
  Application Receipt Date(s): May 24, 2022
• NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed)
  (PAR-20-094)
  National Institute of Mental Health
  Application Receipt Date(s): May 26, 2020; May 25, 2021, May 25, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed)
  (PAR-20-095)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is May 25, 2020.
• NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed)
  (PAR-20-096)
  National Institute of Mental Health
  Application Receipt Date(s): May 26, 2020; May 25, 2021; May 25, 2022
• Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)
  (PAR-20-097)
  National Institute of General Medical Sciences
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Eye Institute
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023
• Medications Development for the Treatment of Alcohol Use Disorder (AUD) or Alcohol-Related Organ Damage (AROD), or the Combination of AUD and AROD (U01 Clinical Trial Optional)
  (RFA-AA-20-007)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): March 26, 2020
• New/Unconventional Animal Models of Alzheimers Disease (R24 Clinical Trial Not Allowed)
  (RFA-AG-21-003)
  National Institute on Aging
  Application Receipt Date(s): October 7, 2020
• Limited Competition: National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) (U24 Clinical Trial Not Allowed)
  (RFA-AG-21-005)
  National Institute on Aging
  Application Receipt Date(s): June 17, 2020.
• Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional)
  (RFA-AG-21-011)
  National Institute on Aging
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): October 2, 2020
• Combating Antibiotic-Resistant Bacteria (CARB) Interdisciplinary Research Units (U19 Clinical Trial Not Allowed)
  (RFA-AI-20-001)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 22, 2020
• Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)
  (RFA-CA-20-004)
  National Cancer Institute
  Application Receipt Date(s): June 2, 2020; November 17, 2020 No late applications will be accepted for this Funding Opportunity Announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)
  (RFA-CA-20-005)
  National Cancer Institute
  Application Receipt Date(s): June 2, 2020; November 17, 2020 No late applications will be accepted for this Funding Opportunity Announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
  (RFA-DK-19-032)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 14, 2020; September 2, 2020; March 2, 2021. All applications are due, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Drug Development Tools Research Grants (U01 Clinical Trial Optional)
  (RFA-FD-20-009)
  Food and Drug Administration
  Application Receipt Date(s): March 17, 2020
• Novel Approaches to Advance Coordinated Registry Networks (CRNs) (U01 Clinical Trial Optional)
  (RFA-FD-20-021)
  Food and Drug Administration
  Application Receipt Date(s): March 13, 2020
• Renewal - Integrated Food Safety System Online Research and Collaboration Development (U18) Clinical Trials Not Allowed
  (RFA-FD-20-023)
  Food and Drug Administration
  Application Receipt Date(s): March 25, 2020
• Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional)
  (RFA-HD-20-003)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): July 3, 2020
• Mendelian Genomics Research Centers (U01 Clinical Trial Optional)
  (RFA-HG-20-007)
  National Human Genome Research Institute
  Application Receipt Date(s): July 15, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mendelian Genomics Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-HG-20-008)
  National Human Genome Research Institute
  Application Receipt Date(s): July 15, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Accelerating Medicine Partnership in Parkinsons disease (AMP PD) data use and analysis (U01 Clinical trials not allowed)
  (RFA-NS-20-027)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): March 18, 2020.
• Limited Competition: Microphysiological Systems Database Center (MPS DC) (U24 Clinical Trials Not Allowed)
  (RFA-TR-20-002)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): March 13, 2020